Filters
Other countries
Results: 1 to 9 of 9
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 345 | 159 |
|
Invitae Hereditary Moyamoya Disease Panel Invitae United States | 2 | 2 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Moyamoya disease: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 3 | 3 |
|
Moyamoya Disease (RNF213 Single Gene Test) Fulgent Genetics United States | 1 | 1 |
|
Moyamoya Disease , Panel Massive Sequencing (NGS) ACTA2,RNF213 Genes Reference Laboratory Genetics Spain | 2 | 2 |
|
Moyamoya Disease Type 2 , Sequencing RNF213 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Results: 1 to 9 of 9
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.